Position in SNY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$621,556
-$87,219 QoQ
Shares Held
14,570
-1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#304
of 712 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Transamerica Financial Advisors, LLC holds $18,529,171 across 15 Drug Manufacturers - General names. SNY ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,030 | $6,033,133 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,868 | $2,167,538 | |
| 3 | ABBV |
AbbVie Inc.
|
8,498 | $2,138,436 | |
| 4 | JNJ |
Johnson & Johnson
|
7,490 | $1,902,235 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,368 | $1,815,253 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,390 | $1,520,591 | |
| 7 | SNY |
Sanofi
This page
|
14,570 | $621,556 | |
| 8 | AZN |
Astrazeneca PLC
|
3,264 | $618,919 |
All Filings in SNY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $621,556 | 14,570 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $708,775 | 14,711 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $458,722 | 9,466 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $377,883 | 8,006 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $271,598 | 5,622 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $282,346 | 5,091 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $277,177 | 5,747 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $274,318 | 4,760 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||